Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Rare diseases

Mike Davis: no licensed photograph is held, so the sector leader plate is shown instead.
Sector leader

Mike Davis

Acting Director, Center for Drug Evaluation and Research

Press citations per month · linked articles
1
0
0
0
0
0
June 2026July 2026Aug 2026Sept 2026Oct 2026Nov 2026to date
1

press citation on 1 topic since 18 Jun 2026 · last quoted 18 Jun 2026

02  Quoted on · 1 of 29 topics

Open the topic

Mike Davis: key facts

Kind of voice
Sector leader
Role
Acting Director, Center for Drug Evaluation and Research
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
18 Jun 2026

04  The signal · where Mike Davis sits on rare diseases

Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
  2. 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
  3. 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
  4. 25=Ann NordgrenClinicianprofessor of clinical genetics at the Karolinska Institutet and senior consultant at Karolinska University Hospital1
  5. 25=Karim MikhailSector leaderActing Director, Center for Biologics Evaluation and Research1
  6. 25=Mike DavisSector leaderActing Director, Center for Drug Evaluation and Research1
  7. 25=Elena MaksimkinaSector leaderhead of the Federal Center for Drug Planning and Provision (FCDPiLO)1
  8. 25=Alexander Hoischen, PhDAcademicprofessor of genomic technologies at Radboud University Medical Center1

Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →

05  On the record · press

What Mike Davis has said

By outlet · linked articles
  • fda.gov1

Where Mike Davis has been quoted

  1. 01Lessons Learned from our Roundtable with Rare Disease Advocatesfda.gov · 18 Jun 2026

Verbatim

“What we need to champion, and what we discussed at length with the advocates, is a tailored regulatory approach to drugs that treat rare diseases.”
Acting Director, Center for Drug Evaluation and Research · Rare diseases · fda.gov · 18 Jun 2026 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.